TWST has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
TWST has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Twist Bioscience's interest expense for the three months ended in Mar. 2024 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.0 Mil.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Twist Bioscience's Operating Income for the three months ended in Mar. 2024 was $ -48.9 Mil. Twist Bioscience's Interest Expense for the three months ended in Mar. 2024 was $ 0.0 Mil. GuruFocus does not calculate Twist Bioscience's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
The historical data trend for Twist Bioscience's Interest Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Twist Bioscience Annual Data | |||||||||||||||||
Trend | Sep16 | Sep17 | Sep18 | Sep19 | Sep20 | Sep21 | Sep22 | Sep23 | |||||||||
Interest Expense | Get a 7-Day Free Trial | -1.29 | -0.79 | -0.37 | -0.08 | -0.01 |
Twist Bioscience Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Interest Expense | Get a 7-Day Free Trial | - | - | - | - | - |
Interest Expense is the amount reported by a company or individual as an expense for borrowed money.
Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Twist Bioscience (NAS:TWST) Interest Expense Explanation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.
Twist Bioscience's Interest Expense for the three months ended in Mar. 2024 was $0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-48.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $74.8 Mil.
Twist Bioscience's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as
GuruFocus does not calculate Twist Bioscience's interest coverage with the available data. |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The higher the ratio, the stronger the company's financial strength is.
Robert F. Werner | officer: Chief Accounting Officer | 2500 FABER PLACE, PALO ALTO CA 94303 |
Dennis Cho | officer: See Remarks | C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080 |
Melissa A. Starovasnik | director | C/O TWIST BIOSCIENCE CORPORATION, 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA 94080 |
Jan Johannessen | director | 5555 NE MOORE CT., HILLSBORO OR 97124 |
William Banyai | director, officer: Chief Operating Officer | C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
Paula Green | officer: VP of Human Resources | C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
James M Thorburn | officer: Chief Financial Officer | C/O ZILOG INC, 532 RACE STREET, SAN JOSE CA 95126 |
Nicolas Barthelemy | director | 1750 BELLA LAGUNA CT, ENCINITAS CA 92024 |
Robert Chess | director | |
Patrick John Finn | officer: VP of Sales and Marketing | C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
Emily M. Leproust | director, officer: President & CEO | C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
Patrick Weiss | officer: VP of Operations | C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
Keith Crandell | director | 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631 |
Kevin Bruce Yankton | officer: Chief Accounting Officer | 1678 S. PIONEER ROAD, SALT LAKE CITY UT 84104 |
Mark Daniels | officer: Chief Compliance Officer & GC | C/O TWIST BIOSCIENCE CORPORATION, 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158 |
From GuruFocus
By Business Wire • 09-05-2023
By GuruFocus Research • 09-14-2023
By GuruFocus Research • 12-07-2023
By GuruFocus Research • 11-29-2023
By Business Wire • 01-24-2024
By Business Wire • 10-03-2023
By GuruFocus Research • 09-26-2023
By GuruFocus Research • 11-20-2023
By Marketwired • 10-06-2023
By Business Wire • 11-14-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.